1. Home
  2. IGIC vs SGP Comparison

IGIC vs SGP Comparison

Compare IGIC & SGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo International General Insurance Holdings Ltd.

IGIC

International General Insurance Holdings Ltd.

HOLD

Current Price

$24.99

Market Cap

1.2B

Sector

Finance

ML Signal

HOLD

Logo SpyGlass Pharma Inc. Common Stock

SGP

SpyGlass Pharma Inc. Common Stock

HOLD

Current Price

$27.61

Market Cap

968.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IGIC
SGP
Founded
2001
2019
Country
Jordan
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
968.0M
IPO Year
2019
2026

Fundamental Metrics

Financial Performance
Metric
IGIC
SGP
Price
$24.99
$27.61
Analyst Decision
Buy
Strong Buy
Analyst Count
1
5
Target Price
$28.00
$45.00
AVG Volume (30 Days)
61.6K
93.1K
Earning Date
05-05-2026
05-15-2026
Dividend Yield
5.25%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$0.13
N/A
Revenue Next Year
$2.54
N/A
P/E Ratio
$9.05
N/A
Revenue Growth
N/A
N/A
52 Week Low
$20.82
$17.06
52 Week High
$29.59
$30.56

Technical Indicators

Market Signals
Indicator
IGIC
SGP
Relative Strength Index (RSI) 34.53 53.04
Support Level $24.51 $25.00
Resistance Level $25.97 $29.90
Average True Range (ATR) 0.59 1.67
MACD -0.12 -0.14
Stochastic Oscillator 6.53 49.22

Price Performance

Historical Comparison
IGIC
SGP

About IGIC International General Insurance Holdings Ltd.

International General Insurance Holdings Ltd is an international specialty insurance and reinsurance group. It underwrites a diversified portfolio of specialty risks including energy, property, construction and engineering, ports and terminals, general aviation, political violence, professional lines, financial institutions, marine, contingency and treaty reinsurance. The company's operating segments include Specialty Longtail, Specialty Short tail and Reinsurance. The majority of revenue is derived from the Specialty Short-tail segment, which comprises business lines with underwriting risks assumed in the form of property and specialty lines insurance and of short-term nature with respect to related claims.

About SGP SpyGlass Pharma Inc. Common Stock

SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.

Share on Social Networks: